Australia's largest stock trading and investment forum Australia's #1 stock forum

PBT

Click for more information

0.00%

0.0¢ prana biotechnology limited

Tanzi AD in a dish mkII, page-22

First 22 Last

Share
Profile

Follow
m123456

1,334 Posts.

22

31/10/18

15:55

Post #: 36335671
Share

Originally posted by skint ↑

Originally posted by m123456
Ah. It was in takedas Q1 reporting. Prana collaboration was listed under 'completed partnership'. But we have never heard anything from prana
Prana did not indicate what form the Takeda collaboration took, money, expertise etc . Just going in with a single MPAC looking for efficacy, was pretty optimistic. On the other hand it is important to know that a drug for PD does no harm to good gut flora, and even there, as pivalde posted above, we don't fully understand that system yet. Maybe IV dosing is an option, or a coated pill to get it past the stomach. I for sure don't know. Perhaps they are trying to develop a screening method for more of Prana's MPACs. It is possibly commercially sensitive info at this point.

Expand

No doubt its commercially sensitive.. Had there been anything positive we wouldn't be sitting at 4.4c now

I don't understand why prana and takeda announced the collaboration, and it was then over in months and NOTHING was disclosed

PBT Price at posting: 4.4¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

CXM

'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 8 more messages in this thread...

First 22 Last

Add PBT (ASX) to my watchlist